EXOMIND & rTMS Research Library
Neuromodulation research has examined food cravings and binge-eating symptoms, but current evidence is preliminary and should not be interpreted as establishing TMS as a stand-alone eating-disorder treatment.
Why this finding matters
Food cravings and binge-eating symptoms can feel difficult to control and often require coordinated psychological, medical and nutritional care. Brain-stimulation research is developing, but current findings do not justify treating TMS as a stand-alone solution.
Research Spotlight
Promising but preliminary
- 18 systematic reviews examined
- 5 included meta-analysis
- RCT findings vary
- Review quality often low
What the evidence suggests
A 2025 umbrella review included 18 systematic reviews, five with meta-analysis. Some randomized trials reported reductions in binge eating and craving, while outcomes for weight and broader eating-disorder symptoms were less consistent.
What this could mean for you
For clients reporting binge eating or loss-of-control eating, comprehensive medical and psychological assessment remains central. TMS may be discussed only as an emerging adjunct where clinically appropriate.
A careful, individualized next step
Research informs—but does not replace—individual clinical judgment. We review symptoms, diagnosis, previous treatment, medications, contraindications, functional goals and the strength of evidence for the proposed protocol. A consultation does not guarantee that treatment will be recommended.
Begin with a responsible clinical discussion
We can review the concern, existing supports and whether another evidence-based pathway should come before—or alongside—any neuromodulation discussion.
Book a Consultation Explore the related Calgary service
Study citation
Longo et al. Neuromodulatory techniques in eating disorders: from brain stimulation to clinical outcomes. PMID: 39740315.
View the original record on PubMed
Educational information only. Findings from pooled research do not predict individual outcomes and may involve devices or protocols that differ from EXOMIND.